Aurora Biosciences and Hyseq Announce Drug Development Collaboration, License Agreement | GenomeWeb

NEW YORK, July 12 - Aurora Biosciences and  Hyseq  have entered into a two-year agreement to share their technologies in order to develop small molecule drug and protein therapeutic candidates, the companies said Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.